Lp(a)] is an independent, genetically determined risk factor for atherosclerotic cardiovascular disease (ASCVD), with levels ...
Lp(a)] is an independent, genetically determined risk factor for atherosclerotic cardiovascular disease (ASCVD), with levels ...
A new analysis has uncovered a potential link between higher prostate cancer risk and genetic variants associated with higher bloodstream levels of the cholesterol-transporting molecule lipoprotein A.
If you've listened to the radio or opened a webpage in the past year, you may have seen or heard ads promoting lipoprotein(a), or Lp(a), testing to help people identify risks for heart disease. But, ...
Very high lipoprotein(a) levels strongly predicted long-term cardiovascular disease risk in healthy women, according to a cohort study, while mild to moderately high levels were not really red flags.
Pro-inflammatory cytokines (TNF-α, IL-6, and IL-1β) are produced in large quantities locally in the joints and subsequently enter the bloodstream. TNF-α and IL-6 may promote LDL metabolism by ...
A nearly 30-year study shows a strong long-term association between very high lipoprotein(a) [Lp(a)] levels and cardiovascular disease (CVD) in women and raises questions about whether broader ...
Higher lipoprotein(a) (Lp[a]) levels are associated with greater baseline coronary artery plaque burden and faster long-term plaque progression. Studies of Lp(a)-lowering therapies are underway.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results